Search Results for “immune” – Page 89 – media

Rheumatoid arthritis may raise COPD risk

New research suggests that people with rheumatoid arthritis are more likely to develop chronic obstructive pulmonary disease (COPD), which is a group of lung diseases that damage the airways and cause problems with breathing.
- Source: medicalnewstoday
- 548
- October 27, 2017
COPD Researches rheumatoid arthritis
NHS to fund gene therapy for ‘bubble babies’

The NHS will fund gene therapy for the first time, with a £500,000 treatment for “bubble baby syndrome”.
- Source: Telegraph
- 1,049
- October 26, 2017
gene immune defiency Market Views NHS therapy
Gemini Reels In $42M to Target Root Causes of Age-Related Blindness

One of the biggest risk factors for vision loss is age. As people grow old, the central part of the retina can become damaged, leading patients to lose the central part of their vision in a condition called age-related macular degeneration (AMD).
- Source: Xconom
- 401
- October 25, 2017
age-related macular degeneration Market Views
Alexion Wins Expanded Approval for Blockbuster Drug Soliris

Alexion Pharmaceuticals Inc. is set to secure even more revenue from its blockbuster drug Soliris, the most expensive drug in the world.
- Source: Biospace
- 813
- October 25, 2017
Alexion New Approvals Soliris
KU Leuven researchers identify new rapid response mechanism against bacterial infections

When bacteria enter our body, they kick-start a powerful immune response. But this chain of reactions doesn't fully account for our immediate responses. Researchers at KU Leuven, Belgium, show that so-called ion channels play a key role as 'first responders'.
- Source: news-medical
- 604
- October 24, 2017
bacteria immune infections
Shingrix approved in the US for prevention of shingles in adults aged 50 and over

GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.
- Source: Gsk
- 619
- October 23, 2017
FDA New Approvals shingles vaccine
AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration

"This collaboration is the first for Harpoon and highlights the high level of industry interest in best-in-class platform technologies. We are excited about partnering with AbbVie to help generate novel T-cell engagers for the treatment of cancer based on the combination of T-cell receptors with TriTACs," said Jerry McMahon, Ph.D., chief executive officer, Harpoon Therapeutics.
- Source: finance.yahoo
- 684
- October 23, 2017
AbbVie Market Views T-cell recruiting biologic
Britain backs GSK’s gene therapy for ‘bubble boy’ syndrome

Gene therapy is designed to deliver a one-off cure for the patient and drugmakers are typically asking a hefty price that is comparable to the combined costs of alternative life-long treatment.
- Source: reuters
- 820
- October 23, 2017
ADA-SCID Company Insight gene Market Views NICE
‘Synthetic gene circuit’ may improve effectiveness of cancer immunotherapy

Synthetic gene circuits that only trigger powerful, tumor-specific immune responses when they detect certain disease markers may help immunotherapies to fight cancer more effectively, according to a new study.
- Source: medicalnewstoday
- 691
- October 20, 2017
cancer immunotherapies Synthetic gene
Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines

Eli Lilly and Company (LLY) and CureVac AG have announced a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac's proprietary RNActive® technology. The companies will use messenger RNA (mRNA) technology that targets tumor neoantigens for a more robust anti-cancer immune response.
- Source: Finance
- 663
- October 20, 2017
immune Market Views mRNA vaccine

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.